FDA 510(k)

Atellica® CH Diazo Direct Bilirubin (D_DBil)

K-Number: K223078 · 2023-06-12

ApplicantSiemens Healthcare Diagnostics, Inc.

Decision Date2023-06-12

Product CodeCIG

Advisory CommitteeCH

DecisionSubstantially Equivalent

Device Summary

Atellica® CH Diazo Direct Bilirubin (D_DBil) is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2023-06-12 under 510(k) number K223078. The device is classified under product code CIG. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Atellica® CH Diazo Direct Bilirubin (D_DBil)?

Atellica® CH Diazo Direct Bilirubin (D_DBil) is a medical device that received FDA 510(k) clearance on 2023-06-12. The listed applicant is Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K223078.

When did Atellica® CH Diazo Direct Bilirubin (D_DBil) receive FDA 510(k) clearance?

Atellica® CH Diazo Direct Bilirubin (D_DBil) received FDA 510(k) clearance on 2023-06-12, under 510(k) number K223078.

Who is the listed applicant for Atellica® CH Diazo Direct Bilirubin (D_DBil)?

The FDA 510(k) record lists Siemens Healthcare Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Atellica® CH Diazo Direct Bilirubin (D_DBil)?

The FDA product code for Atellica® CH Diazo Direct Bilirubin (D_DBil) is CIG.

Other records listing Siemens Healthcare Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253528Atellica IM CA 19-9 II PMA P930027Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer PMA P010007KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS K261364Atellica CH Acetaminophen 2 (ACTM)PMA P930036KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS PMA P250026Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions

View all 87 devices →

Related Devices (Code: CIG)

K251998Atellica CH Diazo Total Bilirubin (D_TBil)Siemens Healthcare Diagnostics, Inc.K222104Atellica® CH Diazo Total Bilirubin (D_TBil)Siemens Healthcare Diagnostics, Inc.K223324Total Bilirubin2Abbott Ireland Diagnostics Division K190807VITROS XT Chemistry Products TBIL-ALKP SlidesOrtho-Clinical Diagnostics, Inc.K171401ELITech Clinical Systems BILIRUBIN TOTAL 4+1, ELITech Clinical Systems BILIRUBIN DIRECT 4+1Elitechgroup

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.